
================================================================================
=== DOCUMENT 1: 8-K - ahr-20231215.htm ===
================================================================================

ahr-20231215
FALSE
0001632970
0001632970
2023-12-15
2023-12-15
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported):
December 15, 2023
American Healthcare REIT, Inc.
(Exact name of registrant as specified in its charter)
Maryland
000-55775
47-2887436
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(I.R.S. Employer
Identification No.)
18191 Von Karman Avenue
,
Suite 300
Irvine
,
California
92612
(Address of principal executive offices)
(Zip Code)
Registrant’s telephone number, including area code:
(
949
)
270-9200
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
None
None
None
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.    ☐
Item 8.01 Other Events.
On December 15, 2023, our board of directors authorized a distribution to our Class T and Class I stockholders of record as of the close of business on December 27, 2023, for the quarter commencing on October 1, 2023 and ending on December 31, 2023. The quarterly distribution will be equal to $0.25 per share of our common stock, which is equal to an annualized distribution rate of $1.00 per share. The fourth quarter distribution will be paid in cash on or about January 16, 2024, only from legally available funds.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
American Healthcare REIT, Inc.
December 15, 2023
By:
/s/ Danny Prosky
Name: Danny Prosky
Title: Chief Executive Officer and President

